Basics Taysha Gene Therapies, Inc. IPO Date: September 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $559.19M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.29% Avg Daily Range (30 D): $0.11 | 5.60% Avg Daily Range (90 D): $0.08 | 4.27% Institutional Daily Volume Avg Daily Volume: 1.28M Avg Daily Volume (30 D): 3.98M Avg Daily Volume (90 D): 2.51M Trade Size Avg Trade Size (Sh.): 217 Avg Trade Size (Sh.) (30 D): 212 Avg Trade Size (Sh.) (90 D): 217 Institutional Trades Total Inst.Trades: 287 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $1.02M Avg Inst. Trade (90 D): $1.11M Avg Inst. Trade Volume: .64M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.51M Avg Closing Trade (30 D): $1.18M Avg Closing Trade (90 D): $1.38M Avg Closing Volume: 982.42K         News May 29, 2025 @ 2:40 AM Taysha Gene Therapies Announces Pricing of Public ... Source: N/A May 2, 2025 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Mar 7, 2025 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Feb 7, 2025 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Dec 6, 2024 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.34 $-.08 $-.07 Diluted EPS $-.34 $-.08 $-.07 Revenue $ 7.22M $ 2.3M $ 2.02M Gross Profit $ $ $ Net Income / Loss $ -86.77M $ -21.53M $ -18.79M Operating Income / Loss $ -88.55M $ -21.42M $ -19.93M Cost of Revenue $ $ $ Net Cash Flow $ -7.39M $ -22.44M $ -18.65M PE Ratio